The TICONC (Ticagrelor-Oncology) Study: Implications of P2Y(12) Inhibition for Metastasis and Cancer-Associated Thrombosis

BACKGROUND: In cancer, platelets may facilitate metastatic spread by a number of mechanisms as well as contribute to thrombotic complications. Ticagrelor, a platelet antagonist- that blocks adenosine diphosphate activation of platelet P2Y(12) receptors, is widely used in the treatment of cardiovascu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wright, Joy R., Chauhan, Meera, Shah, Chirag, Ring, Alistair, Thomas, Anne L., Goodall, Alison H., Adlam, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352224/
https://www.ncbi.nlm.nih.gov/pubmed/34396233
http://dx.doi.org/10.1016/j.jaccao.2020.04.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352224/
https://www.ncbi.nlm.nih.gov/pubmed/34396233
http://dx.doi.org/10.1016/j.jaccao.2020.04.009

Ejemplares similares